The immunological effects of taxanes

O T Chan1, L X Yang

  • 1Department of Radiation Oncology, St Mary's Medical Center, California Pacific Medical Center Research Institute, San Francisco 94117, USA.

Insights

Taxanes, known chemotherapy drugs, also stimulate the immune system to fight cancer. These drugs offer broader therapeutic potential beyond just inhibiting cell division.

Area of Science:

  • Oncology
  • Immunology
  • Pharmacology

Background:

  • Taxanes are widely recognized as effective chemotherapeutic agents for various cancers.
  • Their primary mechanism of action was understood as mitotic inhibition through microtubule stabilization.
  • Emerging evidence suggests taxanes exert significant effects on the immune system.

Purpose of the Study:

  • To explore the less appreciated immunomodulatory effects of taxanes.
  • To investigate the potential of taxanes to suppress neoplasms through immune stimulation.
  • To highlight the broader therapeutic applications of taxanes beyond cell division inhibition.

Main Methods:

  • Review of existing literature on taxane mechanisms of action.
  • Analysis of studies demonstrating taxane effects on immune cells and cancer.
  • Synthesis of data on immunostimulatory and immunomodulatory properties of taxanes.

Main Results:

  • Taxanes exhibit immunostimulatory effects against neoplasms.
  • These agents contribute to cancer suppression via mechanisms beyond direct cell division inhibition.
  • Taxanes demonstrate the capacity to modulate immune functions, including lymphocyte activation.

Conclusions:

  • Taxanes possess multifaceted biological actions, including significant immunomodulatory effects.
  • The immunostimulatory properties of taxanes present novel therapeutic strategies in oncology.
  • Taxanes may have therapeutic applications extending beyond their traditional role in chemotherapy.

Related Concept Videos

Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...